Targeted drugs for cervical cancer work by using target cell drugs to directly kill cancer cells and inhibit their further growth. Therefore, at present, for cervical cancer treatment, targeted drugs for cervical cancer can be chosen for treatment. However, there is no specific targeted drug for cervical cancer. Targeted drugs for cervical cancer include multi-target inhibitors, anlotinib, and immunotherapy inhibitors, nabritumomab or pablizumab. These targeted drugs can improve the quality of life and prolong the survival time of patients to some extent. The main thing for cervical cancer treatment is early detection, early diagnosis and early treatment.